Cargando…
Drug transporter regulation in tumors by DNA methylation
Epigenetic alterations, such as aberrant DNA methylation, are a hallmark of cancer. DNA hypermethylation of the promoter region affects, for example, the expression of tumor suppressor genes and is associated with their transcriptional silencing in tumors. A recent report has provided evidence for e...
Autores principales: | Zolk, Oliver, Fromm, Martin F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334558/ https://www.ncbi.nlm.nih.gov/pubmed/22293136 http://dx.doi.org/10.1186/gm309 |
Ejemplares similares
-
Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates
por: Hacker, Kristina, et al.
Publicado: (2015) -
ecDNA within tumors: a new mechanism that drives tumor heterogeneity and drug resistance
por: Zeng, Xixi, et al.
Publicado: (2020) -
Balance of DNA methylation and demethylation in cancer development
por: Song, Chun-Xiao, et al.
Publicado: (2012) -
DNA methylation: an identity card for brain cells
por: Bender, Ambre, et al.
Publicado: (2013) -
The aging epigenome: DNA methylation from the cradle to the grave
por: Winnefeld, Marc, et al.
Publicado: (2012)